Error: Could not add to watchlist. X

BioMimetic Therapeutics Inc

+ Watchlist
BMTI:US
Acquired
BMTI:US was acquired by WMGI:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.89
Market Cap (USD)
-
Shares Outstanding (m)
28.225
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Medical Equipment & Devices
Sub-Industry
Health Care Supplies

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
BioMimetic Therapeutics, Inc. develops and markets drug-device products for the repair of orthopedic injuries to bond, cartilage, ligaments, and tendons. The Company combines protein therapeutics with tissue scaffolds to stimulate tissue healing and regeneration.
ADDRESS
389 Nichol Mill Lane
Franklin, TN 37067
United States
PHONE
1-615-844-1280
  • Russ Pagano
    VP:Regulatory & Clinical
Show More